ISO 14155:2026 Explained: GCP Requirements for Medical Device Clinical Investigations
Clinical investigations are essential for demonstrating the safety, clinical performance, and effectiveness of medical devices before global market introduction. As regulatory scrutiny increases, manufacturers must adopt internationally recognized Good Clinical Practice (GCP) standards to ensure trials are ethical, scientifically sound, and compliant.
ISO 14155:2026 sets the latest international baseline for medical device clinical investigations involving human participants. Aligning closely with global frameworks—including EU MDR, US FDA expectations, India’s CDSCO GCP guidelines, and ICH GCP E6(R3)—the standard strengthens clinical quality, patient safety, data integrity, and risk-based trial management.
Start Your Medical Device Regulatory Roadmap
What is ISO 14155:2026?
ISO 14155:2026 is the international standard governing Good Clinical Practice (GCP) for medical device clinical investigations involving human subjects.
Key aspects of the standard include:
- Core Scope & Purpose: Establishes standardized requirements for the design, conduct, recording, and reporting of clinical studies to evaluate medical device safety, clinical performance, and effectiveness.
- Participant Protection & Data Credibility: Protects the rights, safety, and well-being of trial participants while ensuring the study design yields scientifically valid and audit-ready clinical evidence.
- Defined Roles & Regulatory Alignment: Defines explicit responsibilities for study sponsors and principal investigators, providing a unified baseline for ethics committees and regulatory authorities during conformity assessments.
- Applicability: Covers pre-market trials, relevant post-market clinical studies, and Software as a Medical Device (SaMD), while excluding In Vitro Diagnostics (IVDs) unless mandated by specific regional rules.
Who Must Comply with ISO 14155?
ISO 14155:2026 applies to all primary stakeholders involved in planning, executing, and reviewing medical device clinical studies:
- Sponsors & Medical Device Manufacturers: Responsible for study initiation, protocol design, trial oversight, risk management, and submitting clinical data for regulatory approvals.
- Contract Research Organizations (CROs): Execution partners tasked with operational trial management, clinical monitoring, data management, and site compliance.
- Principal Investigators (PIs) & Trial Sites: Clinical professionals and healthcare institutions responsible for protocol adherence, participant safety, informed consent, and accurate data collection.
- Ethics Committees (IECs) & IRBs: Independent boards that evaluate study protocols to safeguard trial participant rights, safety, and well-being.
- Notified Bodies & Regulatory Authorities: Auditing agencies (such as CDSCO, US FDA, and EU Notified Bodies) that evaluate ISO 14155 clinical trial data during conformity assessments.
Why ISO 14155:2026 Matters for Medical Device Manufacturers
Regulators increasingly require clinical evidence rather than relying solely on equivalence. Adhering to ISO 14155 provides key strategic benefits:
- Global Regulatory Acceptance: Simplifies multi-region submissions across key markets, including the EU (MDR), US (FDA), India (CDSCO), and Asia-Pacific.
- EU MDR Compliance: Supports clinical evaluation and post-market clinical follow-up (PMCF) requirements necessary for CE Marking under EU MDR.
- Data Credibility: Minimizes regulatory deficiency queries and submission delays.
- Risk Control: Embeds clinical safety into broader product risk management.
Key Principles of Good Clinical Practice (GCP)
1. Protection of Human Subjects
Participant welfare supersedes scientific or commercial interests. Ethics committee approval, informed consent, data privacy, and continuous safety monitoring are mandatory.
2. Scientific Validity
Studies must feature clear clinical endpoints, justified sample sizes, robust statistical plans, and defined inclusion/exclusion criteria within a detailed Clinical Investigation Plan (CIP).
3. Risk-Based Management
Manufacturers must proactively identify trial-related risks—including device operation risks and non-routine clinical procedures—integrating them directly into the device risk file.
Reviewing Medical Device Documentation Gaps helps prevent protocol oversights.
Unsure if your device requires a clinical investigation?
Connect with Operon Strategist to define your regulatory pathway.
Essential Documentation Required Under ISO 14155
Traceable, well-controlled documentation underpins GCP compliance. Key documents include:
- Clinical Investigation Plan (CIP): The primary study protocol.
- Investigator’s Brochure (IB): Detailed clinical and non-clinical data on the device.
- Informed Consent Forms (ICF) & Ethics Committee Approvals
- Case Report Forms (CRFs) & Monitoring Reports
- Device Accountability Logs & Safety Reports
- Final Clinical Investigation Report
Maintaining comprehensive documentation relies on a structured Design History File (DHF) and robust technical file management.
For deeper insights into study structuring, explore our guide on Medical Devices Clinical Investigations.
Global Regulatory Alignment & Common Compliance Challenges
ISO 14155:2026 harmonizes with major international regulations, including EU MDR (2017/745), FDA Investigational Device Exemption (IDE) rules, CDSCO Medical Devices Rules, ISO 14971, and ISO 13485. Conducting Regulatory Due Diligence helps uncover evidence gaps early in global market planning.
Common Compliance Pitfalls:
- Weak CIP Design: Ambiguous endpoints or missing statistical rationale.
- Inadequate Adverse Event Reporting: Unclear adverse event timelines and evaluation criteria.
- Poor Site Monitoring: Lack of ongoing oversight regarding protocol adherence and device accountability.
- Incomplete Risk Integration: Failing to update ISO 14971 risk files with trial findings.
How Operon Strategist Can Help
Navigating clinical requirements requires a clear regulatory roadmap before engaging clinical sites or research partners. Operon Strategist guides medical device manufacturers in establishing compliant regulatory and clinical evaluation strategies:
- Clinical Investigation Need Determination: We analyze your device classification, intended use, and existing technical data to determine whether an ISO 14155 study is required under EU MDR, US FDA, CDSCO, or other global frameworks.
- Regulatory & Clinical Strategy Planning: We define cost-effective compliance roadmaps, identifying data gaps prior to protocol finalization.
- Risk & QMS Integration: We align your ISO 13485 Quality System and ISO 14971 Risk Management files with GCP standards.
- Technical Documentation Support: We assist in structuring clinical evaluation plans (CEP) and technical files for smooth regulatory reviews.
- CRO Advisory & Partner Selection: We help define study parameters and select qualified Contract Research Organizations (CROs).
(Note: Operon Strategist provides regulatory consulting and strategic clinical pathway guidance. Actual clinical investigation execution and trial documentation management are conducted by qualified Contract Research Organizations).
Conclusion
ISO 14155:2026 establishes a rigorous framework for conducting safe, ethical, and scientifically valid medical device clinical trials. Integrating ISO 14155 principles early into your regulatory and quality systems mitigates submission risks, accelerates global market access, and strengthens regulator confidence.
Preparing for global submissions?
Partner with Operon Strategist to streamline your regulatory and clinical evaluation strategy.
FAQ's
What is ISO 14155:2026?
It is the international Good Clinical Practice (GCP) standard for designing, conducting, and reporting medical device clinical investigations in human subjects.
Does ISO 14155 apply to Software as a Medical Device (SaMD)?
Yes, relevant sections apply to SaMD, focusing on analytical validity, scientific validity, and clinical performance.
Does ISO 14155 apply to In Vitro Diagnostics (IVDs)?
No, IVDs are generally excluded from ISO 14155 and governed by separate diagnostic clinical performance standards.
How does ISO 14155 relate to ISO 14971?
ISO 14155 mandates that clinical trial risks be continuously integrated into the device’s overall ISO 14971 risk management file.
Does Operon Strategist execute clinical trials directly?
No. Operon Strategist provides strategic regulatory advisory and clinical need assessments; trial execution is performed by specialized CRO partners.